Latest Licensing News

Alara Resources has reported its strongest quarterly copper concentrate production and dispatch at the Al Wash-hi Majaza Mine, alongside expanded exploration efforts across Oman and strengthened financial footing through new loan facilities.

Legacy Iron Ore Limited has completed phase I mining at its Mount Celia gold operation and made significant progress on the Mount Bevan magnetite project, underpinning its growth strategy in Western Australia’s mineral sector.

Red Metal Limited reports significant technical progress in rare earth processing at its Sybella project alongside advancing gold and copper exploration across multiple Australian sites. The company’s strategic stake in Maronan Metals gains momentum amid rising metal prices.

Triangle Energy has secured new offshore and onshore permits in the Philippines while initiating legal action against JV partners in Western Australia, signaling a strategic pivot and operational challenges ahead.

Avecho Biotechnology is on the cusp of completing patient dosing in its pivotal Phase III CBD insomnia trial, backed by a recent $2.5 million capital raise and patent allowances in the US and Europe.

Australian Critical Minerals Limited (ACM) has unveiled detailed exploration plans for its Peru projects, highlighting the Flint Project’s compelling high-grade gold and silver targets with drilling scheduled for early 2026.

Avenira Limited has made significant strides in developing its Wonarah Phosphate Project, bolstered by strategic operational appointments and advancing infrastructure plans. Meanwhile, exploration at the Jundee South Gold Project is set to commence in 2026 amid ongoing regulatory challenges.

Gold Hydrogen Limited has reported successful drilling results confirming high-purity Natural Hydrogen and Helium at its Ramsay Project in South Australia, setting the stage for commercial pilot testing and green methanol development.

Far East Gold’s December quarter report highlights significant high-grade gold discoveries at its Idenburg Project and a key regulatory approval that paves the way for accelerated development.

Mesoblast Limited reported a 60% jump in Ryoncil sales to US$35 million for the December quarter, alongside securing a US$125 million credit facility that enhances its financial flexibility and supports ongoing clinical development.

Starpharma reports strong progress in strategic collaborations and internal drug development, alongside a 70% surge in Viraleze™ online sales and a solid $18.2 million cash position.

Mayne Pharma delivered a robust FY25 performance with a 105% surge in underlying EBITDA and launched key dermatology products as it outlines a strategic growth path for FY26.